Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced it is acquiring approximately 71 acres of land in Medicine Hat, Alberta, where the Company intends shortly to commence construction on a new high-technology hybrid greenhouse cannabis production facility.

To this end, the Company has signed a memorandum of understanding with the City of Medicine Hat, concerning terms and a general understanding of potential transactions, including a prospective 10-year, 42 MW energy supply agreement.

Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely with its medical advisors to support patients, enhance research and to advance the scientific understanding of cannabinoid therapy.

With over 400,000 medical records and almost 7 million data points, and growing, Strainprint is the most trusted source for strain efficacy and patient use data. Dr. MacCallum and Dr. Schecter will jointly lead Strainprint's Medical Advisory Board as Co-chairs and Dr. Elterman will focus on specific cannabinoid studies through the University Health Network.

Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF), through its subsidiary Pure Natures Wellness Inc. (o/a Aphria), is pleased to announce that it entered into a major wholesale supply agreement with HydRx Farms, Ltd.

A Canadian appellate court has, for the first time, ruled unconstitutional a contentious mandatory minimum provision that saw individuals imprisoned for 6 months for producing as few as 6 marijuana plants.

The provision, ss 7(2)(b)(i) of the federal Controlled Drugs and Substances Act, was introduced by the previous Harper government. It enabled Crown prosecutors to seek a minimum jail sentence of 6 months for offenders found producing more than 5 plants if the production could be shown to be for the purposes of trafficking.

There is much discussion about the coming legalisation of marijuana in Canada, expected in about a year.

Certainly some of that discussion involves levels of intoxication/impairment and driving.

THC is the active chemical in cannabis. The Canadian government is proposing limits of  THC in blood levels similar to the concept of limits for blood alcohol content in current drinking and impaired driving laws.

Jonathan Zaid says that medical marijuana users may be unfairly treated under the proposed future laws. He is the executive director of Canadians for Fair Access to Medical Marijuana (CFAMM) is a federal non-profit organization medical cannabis patient rights group.

July 1 brings Canada Day, an annual celebration of national unity. This year, it’s also an important milestone: As of today, Canada is exactly one year away from being only the second country on Earth to fully legalize cannabis for adult use. (Thanks for stealing our thunder, Uruguay.) It’s an exciting time to be alive—how often do you get to see federal prohibition repealed?—and the change carries huge ramifications for the legal, medical, financial, and political spheres. Here are six things to watch for as the 12-month countdown plays out.

1. Canadian Celebrities Jumping on the Canna-Bandwagon

With the exception of the internet boom in the late 1990s, you'd struggle to find an industry with long-term growth potential as high as legal weed -- and marijuana stock investors have taken notice.

Depending on your preferred source, the legal weed industry has the potential to grow by an average of 23% to 27% on an annual basis over the next five to 10 years. However, a pretty clear consensus among the various reports estimating growth in the legal pot industry suggest that U.S. sales are poised to triple or quadruple between 2016-2017 and 2021. It's certainly not hard to get excited about an industry with sustainable growth of around 25% per year.

Earlier this month on The Tonight Show, Miley Cyrus told host Jimmy Fallon that she’d quit using marijuana because she had a dream “that I would die during my monologue on SNL for some reason, just get so stoned that I just died.”

Bill Panagiotakopoulos was surveying construction on his gated property outside Hamilton when he got the call he had been dreaming about for years: his company, Beleave Inc., was officially Canada’s 44th licensed marijuana producer.

The entrepreneur debated whether to answer the call from an unknown number that fateful mid-May afternoon, but as soon as he heard he was on a conference call with Health Canada representatives, he broke into a run, frantically searching for a quiet place to talk.

Panagiotakopoulos jumped into his truck just in time to hear the news: Beleave had the green light to grow pot.